Pomegranate Juice May Inhibit the Spread of Cancer

This Drink Packs a Big Punch




The exotic red fruit known as pomegranate is making headlines again. Researchers at the University of California, Riverside, have identified components in pomegranate juice that inhibit the movement of cancer cells and the metastasis of prostate cancer to the bone.

The researchers attribute this effect to four key ingredients in the pomegranate: phenylpropanoids, hydrobenzoic acids, flavones and conjugated [types of polyunsaturated] fatty acids. “Having identified them, we can now modify cancer-inhibiting components in pomegranate juice to improve their functions and make them more effective in preventing prostate cancer metastasis, leading to more effective drug therapies,” says Manuela Martins-Green, a professor of cell biology at the university.

She adds: “Because the genes and proteins involved in the movement of prostate cancer cells are essentially the same as those involved in the movement of other types of cancer cells, the same modified components of the juice could have a much broader impact in cancer treatment.”

Edit ModuleShow Tags

More from Natural Awakenings

Eating Apples and Tomatoes Repairs Lungs

Fresh tomatoes and fruit, especially apples, help heal damaged lungs of ex-smokers and can slow the natural decline of lung function that typically occurs after age 30.

Gooseberries are Good for the Gut

Malaysian subjects with gastrointestinal problems had less pain, vomiting and sleep loss when receiving an ayurvedic remedy known as Indian gooseberry.

Chocolate and Olive Oil Help Heart Health

Italians eating dark chocolate combined with olive oil had lower cholesterol and blood pressure in just 28 days.

Lutein in Greens and Eggs Slows Cognitive Aging

In a University of Illinois study, adults that ate large amounts of leafy greens, avocados and eggs had levels of lutein, a brain and eye nutrient, on par with younger people.

Tree Nuts Cut Colon Cancer Relapse

Two or more ounces of tree nuts a week sharply reduced cancer recurrence and premature death risk in patients with Stage III colon cancer.
Edit ModuleShow Tags
Edit ModuleShow Tags